By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Belgian drug discovery company Galapagos today announced it increased its shares capital by about €350,000 ($430,000) through the exercise of employee warrants.

The firm issued 40,160 new ordinary shares today for an average of €8.71 per share. Following today's capital increase, the company has a share capital of more than €129 million with a total of almost 24 million shares outstanding.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.